✦ LIBER ✦

Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease

✍ Scribed by Emanuele Durante-Mangoni; Domenico Iossa; Daniela Pinto; Lucia De Vincentiis; Enrico Ragone; Riccardo Utili

Book ID: 119229825
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 139 KB
Volume: 43
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2010.12.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of peginterferon-rib

Safety and efficacy of peginterferon-ribavirin treatment in hepatitis C patients with heart disease

✍ E. Durante-Mangoni; D. Iossa; D. Pinto; R. Utili 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Safety and efficacy of peginterferon alp

Safety and efficacy of peginterferon alpha-2b plus ribavirin in pre-cirrhotic and cirrhotic patients with chronic hepatitis C

✍ Marrache, Frederic; Ripault, Marie Pierre; Consigny, Yann; Hatem, Dominique Caza 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Safety and efficacy of peginterferon plu

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

✍ F. Marrache; Y. Consigny; M. P. Ripault; D. Cazals-Hatem; M. Martinot; N. Boyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Efficacy and safety of peginterferon alp

Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C

✍ Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma

794 EFFICACY OF RIBAVIRIN PLUS PEGINTERF

794 EFFICACY OF RIBAVIRIN PLUS PEGINTERFERON-ALFA IN ELDERLY PATIENTS WITH CHRONIC HEPATITIS C

✍ T. Honda; Y. Katano; M. Doizaki; K. Hayashi; M. Ishigami; I. Nakano; F. Urano; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Commentary: efficacy and safety of ribav

Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C

✍ Hadziyannis, S. J.; Sevastianos, V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB